Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dietary saturated fat and low-grade inflammation modified by accelerometer-measured physical activity in adolescence: results from the GINIplus and LISA birth cohorts.

BMC public health·2019

Same author

The Role of Socioeconomic Status in the Association of Lung Function and Air Pollution-A Pooled Analysis of Three Adult ESCAPE Cohorts.

International journal of environmental research and public health·2019

Same author

Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.

Nature genetics·2019

Same author

Longitudinal trends of serum IgE and IL5RA expression throughout childhood are associated with asthma but not with persistent wheeze.

Allergy·2019

Same author

Residential greenness and blood lipids in urban-dwelling adults: The 33 Communities Chinese Health Study.

Environmental pollution (Barking, Essex : 1987)·2019

Same author

Effects of smoking bans on passive smoking exposure at work and at home. The European Community respiratory health survey.

Indoor air·2019

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Real-time Imaging of Leukotriene B₄ Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

TLR4 gene variants modify endotoxin effects on asthma.

Monika Werner¹, Rebekka Topp, Katrin Wimmer

¹Institute of Epidemiology, GSF National Research Center for Environment and Health, Neuherberg, Germany.

The Journal of Allergy and Clinical Immunology

|August 5, 2003

Summary

Environmental endotoxin exposure significantly increases asthma risk in individuals without TLR4 gene variations. Those with specific TLR4 polymorphisms show a reduced, though not statistically significant, association with asthma and wheeze.

More Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

Related Experiment Videos

Last Updated: Jul 8, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Real-time Imaging of Leukotriene B₄ Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

Area of Science:

Environmental Health
Immunology
Genetics

Background:

Environmental endotoxin exposure plays a role in immune development and asthma pathogenesis.
Investigating gene-environment interactions is crucial for understanding asthma etiology.

Purpose of the Study:

To determine if Toll-like receptor 4 (TLR4) gene variations modify the association between house dust endotoxin levels and asthma.
To analyze the impact of G299/I399 polymorphisms in the TLR4 gene on asthma risk and symptoms.

Main Methods:

Cross-sectional study within the German arm of the European Community Respiratory Health Survey.
Multivariate logistic regression and nonparametric methods analyzed endotoxin exposure, asthma, and bronchial hyperreactivity (BHR).
Stratification was performed based on the presence or absence of G299/I399 polymorphisms in the TLR4 gene.

Main Results:

In non-carriers of TLR4 polymorphisms, elevated endotoxin levels were significantly associated with increased asthma prevalence (OR 6.24 and 4.54).
Carriers of G299/I399 polymorphisms showed a trend towards a lower risk of asthma (OR 0.67 and 1.33).
Similar attenuated associations between endotoxin exposure and wheeze were observed in polymorphism carriers.

Conclusions:

The G299/I399 polymorphisms in the TLR4 gene appear to modify the immune response to environmental endotoxin exposure.
Further research is needed to elucidate the precise functional mechanisms underlying this gene-environment interaction in asthma.